This is a working overview of prothymosin alpha, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-02. Anything still debated is marked as such rather than presented as settled.
胸腺素α1对免疫系统的影响涉及多种细胞类型。研究表明，它可促进未成熟T细胞向成熟T细胞分化，并增强T细胞对抗原刺激的增殖反应。树突状细胞在Tα1存在下表达更高水平的共刺激分子，从而更有效地呈递抗原。此外，自然杀伤细胞的活性也观察到上升。这些效应并非直接杀伤病原体，而是调节宿主免疫应答的强度与方向。
在信号层面，Tα1可能通过Toll样受体等模式识别受体发挥作用。部分实验显示，它能激活髓样分化因子88依赖的通路，进而促进核因子κB进入细胞核。这导致白细胞介素2、干扰素γ和白细胞介素12等细胞因子的转录增加。这些细胞因子偏向辅助性T细胞1型应答，有助于细胞免疫。然而，具体受体和结合位点尚未完全确定，不同实验模型的结果存在差异。
临床研究将Tα1用于慢性病毒感染、肿瘤辅助治疗和疫苗佐剂等场景。部分试验报告了免疫学指标改善，但临床终点获益在不同研究中并不一致。系统综述指出，研究间在人群、剂量和联合方案上差异较大，难以汇总结论。因此，Tα1的确切临床地位仍属开放问题，需要更多高质量随机对照试验来澄清。其机制研究也需从体外实验向体内模型推进。
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
| Property | Value | Notes |
|---|---|---|
| 主要靶细胞 | T细胞、树突状细胞 | 也影响NK细胞 |
| 信号通路 | TLR/MyD88/NF-κB | 部分实验模型 |
| 细胞因子偏向 | Th1型 | 增加IL-2、IFN-γ |
| 给药途径 | 皮下注射 | 临床常用 |
| 半衰期 | 约2小时 | 血浆中较短 |
Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
==== 2020s ==== On March 20, 2020, due to the COVID-19 pandemic, Starbucks closed all the café-only stores in the United States for two weeks. During that time, only drive-thru and delivery-only services were to function. According to the company representatives, all workers were to be paid for the next 30 days whether they went to work or stayed home. COVID-19 lockdowns caused Starbucks to suffer a general 10% sales decrease, and a 50% decrease in China where quarantine measures were especially strict. In May 2020, the company asked for reduced rent from landlords due to the decrease in sales. In June 2020, during the COVID-19 pandemic in the United States, the company announced that it would close 400 of its locations in the US/Canada region over the subsequent 18 months as it moves from the coffee house concept to "convenience-led" formats with drive-through and curbside pickup. Starbucks announced that it planned to open 300 stores that would primarily focus on carryout and pickup orders. The new stores would work with the Starbucks mobile app for prepayment by the customer before arrival to pick up the order. The layout of some stores would also be modified with a separate counter for picking up mobile orders. In December 2020, Starbucks announced that it is planning to increase its store count to about 55,000 by 2030, up from roughly 33,000. Bloomberg reported in July 2022 that the company was, through investment bank Houlihan Lokey, exploring selling its stores in the United Kingdom.
=== Women with cancer === In women with cancer, radiation therapy and chemotherapy can damage the ovarian reserve. In such cases, a pre-treatment AMH is useful in predicting the long-term post-chemotherapy loss of ovarian function, which may indicate fertility preservation strategies such as oocyte cryopreservation. A post-treatment AMH is associated with decreased fertility. Granulosa cell tumors of the ovary secrete AMH, and AMH testing has a sensitivity ranging between 76 and 93% in diagnosing such tumors. AMH is also useful in diagnosing recurrence of granulosa cell tumors.
Local anesthetics: Amoxecaine, butamben, butethamine, calocaine, farmocaine, isobutamben, leucinocaine, risocaine, tetracaine, topicaine, tutocaine. Benzocaine is used to make Aminostimil, bentiromide, Cetaben, Declopramide, Leteprinim, Procaine, Procainamide, Sematilide, Thihexinol, Votracon Miscellaneous: Acedoben, aminohippuric acid, benaxibine, CAM [40449-96-5], CJM-126 [6278-73-5], CPI-1189 [183619-38-7], dinalin [58338-59-3], JW-55 [664993-53-7], K-AM [78307-27-4], LY-188544 [97042-55-2], nufenoxole, pabofen (see under Phenatine) pafencil, S-1688 [30194-63-9], tacedinaline, votracon & xenazoic acid. & Tafamidis
The longest word in Spanish is esternocleidomastoideitis (inflammation of the sternocleidomastoid muscle, 30 letters). Runners-up are anticonstitucionalmente ([proceeding in a manner that is] contrary to the constitution (anticonstitutionally)) and electroencefalografistas (specialists that do electrical scans on brains (electroencephalographists)), both 23 letters. The word anticonstitucionalmente is usually considered the longest word in general use. This word can be made even longer by the addition of the absolute superlative suffix, rendering anticonstitucionalísimamente (i.e.: "very strongly against the constitution"). Some dictionaries (but not the RAE dictionary) removed its root word (anticonstitucional) in 2005, causing comments about it not "being a valid word anymore" and suggesting the use of inconstitucional as a replacement.
Sources: en.wikipedia.org
=== Machine Learned Interatomic Potentials === Machine Learned Interatomic Potentials (MLIPs) are computational models that use machine learning techniques to approximate the interactions between atoms in a material. Their primary goal is to predict quantities such as total energy, atomic forces, and stresses with accuracy approaching that of quantum mechanical methods, such as Density Functional Theory (DFT), while maintaining lower computational cost. MLIPs are typically trained on datasets generated from first-principles calculations, where atomic configurations are paired with corresponding energies and forces. The models learn an approximation to the potential energy surface (PES), which describes how the energy of a system varies with atomic positions. Forces acting on atoms are then obtained as the gradient of the predicted energy, ensuring consistency with physical laws. MLIPs have been widely applied in molecular dynamics simulations and materials science, enabling the study of complex phenomena such as defect formation, phase transformations, and chemical reactions. In high-energy environments, such as radiation damage cascades, energy-based MLIPs are generally preferred because they ensure energy conservation and provide more stable simulations under extreme conditions, particularly when combined with short-range repulsive corrections such as the Ziegler–Biersack–Littmark (ZBL) potential.
== Standards == In addition to its library services, the Library of Congress is actively involved in various standard activities in areas related to bibliographical and search and retrieval standards. Areas of work include MARC standards, Metadata Encoding and Transmission Standard (METS), Metadata Object Description Schema (MODS), Z39.50 and Search/Retrieve Web Service (SRW), and Search/Retrieve via URL (SRU). The Law Library of Congress "seeks to further legal scholarship by providing opportunities for scholars and practitioners to conduct significant legal research. Individuals are invited to apply for projects which would further the multi-faceted mission of the law library in serving the U.S. Congress, other governmental agencies, and the public."
The course of the disease varies greatly. Some people have mild short-term symptoms, but in most the disease is progressive for life. Around 25% will have subcutaneous nodules (known as rheumatoid nodules); this is associated with a poor prognosis.
Sources: en.wikipedia.org
它促进未成熟T细胞分化并增强成熟T细胞的增殖与细胞因子分泌。这些作用有助于放大抗原特异性免疫应答。
目前认为它可能通过Toll样受体等模式识别受体传递信号，但精确的受体身份和结合机制尚未完全阐明。
不同试验在患者选择、给药方案、联合治疗和终点定义上差异很大。这些异质性使得跨研究比较困难，结论难以统一。
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.